NZ630210A - Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids - Google Patents
Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acidsInfo
- Publication number
- NZ630210A NZ630210A NZ630210A NZ63021013A NZ630210A NZ 630210 A NZ630210 A NZ 630210A NZ 630210 A NZ630210 A NZ 630210A NZ 63021013 A NZ63021013 A NZ 63021013A NZ 630210 A NZ630210 A NZ 630210A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alpha tocopherol
- fatty acids
- polyunsaturated fatty
- compositions including
- nutritional compositions
- Prior art date
Links
- 235000016709 nutrition Nutrition 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000002076 α-tocopherol Substances 0.000 title abstract 2
- 235000004835 α-tocopherol Nutrition 0.000 title abstract 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 title abstract 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 229940114079 arachidonic acid Drugs 0.000 abstract 2
- 235000021342 arachidonic acid Nutrition 0.000 abstract 2
- 235000013350 formula milk Nutrition 0.000 abstract 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 230000004641 brain development Effects 0.000 abstract 1
- 230000003931 cognitive performance Effects 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pediatric Medicine (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261610799P | 2012-03-14 | 2012-03-14 | |
| PCT/US2013/029611 WO2013138157A1 (en) | 2012-03-14 | 2013-03-07 | Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ630210A true NZ630210A (en) | 2016-05-27 |
Family
ID=47892068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ630210A NZ630210A (en) | 2012-03-14 | 2013-03-07 | Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20150025133A1 (enExample) |
| EP (1) | EP2825065A1 (enExample) |
| CN (1) | CN104427887A (enExample) |
| CA (1) | CA2867438A1 (enExample) |
| HK (1) | HK1205645A1 (enExample) |
| IL (1) | IL234553A (enExample) |
| IN (1) | IN2014DN08200A (enExample) |
| MX (1) | MX2014011056A (enExample) |
| NZ (1) | NZ630210A (enExample) |
| PH (1) | PH12014502024A1 (enExample) |
| SG (1) | SG11201405709SA (enExample) |
| WO (1) | WO2013138157A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201507210XA (en) | 2013-03-13 | 2015-10-29 | Abbott Lab | Infant nutritional product with rrr alpha-tocopherol |
| SG11201507219WA (en) * | 2013-03-13 | 2015-10-29 | Abbott Lab | Prenatal and lactation supplements to enhance central nervous system development of offspring |
| US9980939B2 (en) | 2013-03-13 | 2018-05-29 | Abbott Laboratories | Composition for enhancing newborn infant cognitive, brain and/or CNS development and method of using same |
| US20160279095A1 (en) * | 2013-11-12 | 2016-09-29 | Abbott Laboratories | Use of nutritional compositions including natural vitamin e, and polyunsaturated fatty acid |
| RU2692488C1 (ru) * | 2013-12-13 | 2019-06-25 | Нестек С.А. | Использование модифицированной сладкой молочной сыворотки и детской смеси, содержащей модифицированную сладкую молочную сыворотку, для стимулирования постнатального развития центральной нервной системы и соответствующих когнитивных функций ребенка грудного возраста |
| CN106470547B (zh) * | 2014-05-08 | 2020-10-09 | 帝斯曼知识产权资产管理有限公司 | 包含10-羟基-2-癸烯酸的方法和组合物 |
| WO2016086128A1 (en) | 2014-11-25 | 2016-06-02 | Abbott Laboratories | Method of improving visual processing, visual acuity, or both by administering compositions comprising rrr-alpha-tocopherol and carotenoid to infants |
| WO2016086151A1 (en) * | 2014-11-26 | 2016-06-02 | Abbott Laboratories | Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic |
| WO2016086157A1 (en) * | 2014-11-26 | 2016-06-02 | Abbott Laboratories | Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein |
| WO2017048708A1 (en) * | 2015-09-16 | 2017-03-23 | Abbott Laboratories | Reduced fat, shelf stable liquid nutritional composition |
| CN108471796A (zh) * | 2015-12-14 | 2018-08-31 | 雀巢产品技术援助有限公司 | 用于促进脑的髓鞘形成的营养组合物和婴儿配方食品 |
| WO2017106597A1 (en) * | 2015-12-17 | 2017-06-22 | Abbott Laboratories | Extruded nutritional product and method of making the same |
| CN108065401A (zh) * | 2016-11-11 | 2018-05-25 | 宋玉明 | 一种生长咀嚼片 |
| MX2019010742A (es) * | 2017-05-04 | 2020-02-13 | Univ Leland Stanford Junior | Composiciones de alimento y kits promotoras del neurodesarrollo, sistemas y metodos relacionados con las mismas. |
| CN110996684A (zh) * | 2017-08-22 | 2020-04-10 | 雀巢产品有限公司 | 性别特异性合成营养组合物以及包含其的营养体系产品 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7090862B2 (en) * | 2001-03-30 | 2006-08-15 | Abbott Laboratories | Method of improving the antioxidant status of an infant |
| WO2003017945A2 (en) * | 2001-08-24 | 2003-03-06 | Martek Biosciences Boulder Corporation | Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum |
| US7867541B2 (en) * | 2003-04-14 | 2011-01-11 | Mead Johnson Nutrition Company | Compositions and methods of formulation for enteral formulas containing sialic acid |
| US7090879B2 (en) * | 2004-03-18 | 2006-08-15 | Abbott Laboratories | Nutritional formula containing select carotenoid combinations |
| US7829126B2 (en) * | 2005-10-26 | 2010-11-09 | Abbott Laboratories | Infant formulas containing docosahexaenoic acid and lutein |
| US20070166354A1 (en) * | 2005-10-26 | 2007-07-19 | Bridget Barrett-Reis | Method of reducing the risk of retinopathy of prematurity in preterm infants |
| CN100391353C (zh) * | 2006-01-06 | 2008-06-04 | 石家庄三鹿集团股份有限公司 | 新生婴儿配方奶粉 |
| US20080003330A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
| ES2732293T3 (es) * | 2007-02-22 | 2019-11-21 | Childrens Hospital & Res Center At Oakland | Formulaciones de ácidos grasos y métodos para el uso de las mismas |
| CN102368913A (zh) * | 2009-04-01 | 2012-03-07 | 雀巢产品技术援助有限公司 | 降低肥胖的风险 |
| CN102132742A (zh) * | 2010-12-29 | 2011-07-27 | 九三粮油工业集团有限公司 | 一种具有益智功效的食用营养油 |
| WO2012092085A1 (en) * | 2010-12-30 | 2012-07-05 | Abbott Laboratories | Low calorie infant formula with improved physical attributes |
| CN201973996U (zh) * | 2011-01-07 | 2011-09-14 | 广东科龙模具有限公司 | 一种防变形冰箱门体 |
| WO2013101494A1 (en) * | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Two-phase mixable nutritional composition including locust bean gum |
-
2013
- 2013-03-07 IN IN8200DEN2014 patent/IN2014DN08200A/en unknown
- 2013-03-07 CA CA2867438A patent/CA2867438A1/en not_active Abandoned
- 2013-03-07 NZ NZ630210A patent/NZ630210A/en not_active IP Right Cessation
- 2013-03-07 HK HK15106197.1A patent/HK1205645A1/xx unknown
- 2013-03-07 US US14/384,739 patent/US20150025133A1/en not_active Abandoned
- 2013-03-07 EP EP13710266.1A patent/EP2825065A1/en not_active Withdrawn
- 2013-03-07 MX MX2014011056A patent/MX2014011056A/es unknown
- 2013-03-07 SG SG11201405709SA patent/SG11201405709SA/en unknown
- 2013-03-07 CN CN201380023797.0A patent/CN104427887A/zh active Pending
- 2013-03-07 WO PCT/US2013/029611 patent/WO2013138157A1/en not_active Ceased
-
2014
- 2014-09-09 IL IL234553A patent/IL234553A/en not_active IP Right Cessation
- 2014-09-11 PH PH12014502024A patent/PH12014502024A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL234553A (en) | 2017-11-30 |
| CA2867438A1 (en) | 2013-09-19 |
| EP2825065A1 (en) | 2015-01-21 |
| CN104427887A (zh) | 2015-03-18 |
| WO2013138157A1 (en) | 2013-09-19 |
| HK1205645A1 (en) | 2015-12-24 |
| PH12014502024A1 (en) | 2014-11-24 |
| US20150025133A1 (en) | 2015-01-22 |
| SG11201405709SA (en) | 2014-10-30 |
| IN2014DN08200A (enExample) | 2015-05-01 |
| MX2014011056A (es) | 2015-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014502024A1 (en) | Nutritional compositions including rrr-alpha tocopherol and polyunsaturated fatty acids | |
| NZ709083A (en) | Eicosapentaenoic acid (epa) formulations | |
| PH12014500105A1 (en) | Fatty acid compositions | |
| IL266231A (en) | Omega-3 polyunsaturated fatty acid compounds enriched in dpa in the form of a free acid phase fat | |
| PH12014501828A1 (en) | Methods, compositions, and devices for supplying dietary fatty acid needs | |
| GB2459809A (en) | Fatty acid formulations and methods of use thereof | |
| NZ618734A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| MX2016004487A (es) | Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados. | |
| EA201600471A1 (ru) | Экстрагированный растительный липид, содержащий длинноцепочечные полиненасыщенные жирные кислоты | |
| SG10201810439SA (en) | Production of long chain polyunsaturated fatty acids in plant cells | |
| TW201613488A (en) | Nutritional compositions containing oil blends and uses thereof | |
| ZA201400620B (en) | Eicosapentaenoic acid-producing microoganisms, fatty acid compositions, and methods of making and uses thereof | |
| WO2011097276A8 (en) | Methods and compositions for treating arthritis with docosahexaenoic acid | |
| GEP201606568B (en) | Compositions for the treatment of neurologic disorders | |
| EP2506848A4 (en) | SUBSTANCES TO REDUCE THE IMPACT OF HARD CARDIAL EVENTS CONTAINING AN EXTRACT OF RED FERMENTED RICE AND A MULTIPLE UNSATURATED OMEGA-3 FATTY ACID OR DERIVATIVES THEREOF | |
| HUE051850T2 (hu) | Többszörösen telítetlen zsírsavak 2-hidroxi-származékai, gyógyszerként történõ alkalmazásra | |
| PH12015502057A1 (en) | Method of enhancing bioavailability of dha and other lipid-soluble nutrients | |
| CL2016001453A1 (es) | Composiciones sintéticas de leche que comprenden ácidos grasos poliinsaturados (pufa) para promover el establecimiento saludable de la función cognitiva en infantes varones y hembras y niños y niñas. | |
| WO2016040570A3 (en) | Dietary emulsion formulations and methods for using the same | |
| WO2012153345A9 (en) | Docosahexaenoic acid (dha) as polyunsaturated free fatty acid in its directly compressible powder form and method of isolation thereof | |
| MX362260B (es) | Produccion de acidos grasos omega-3 a partir de especies de pythium. | |
| FR3009955B1 (fr) | Composition a base d'acide gras polyinsature et de vitamine d destinee a une administration par voie orale pour ameliorer la qualite de la chevelure | |
| EA201692398A1 (ru) | Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол | |
| GB201209344D0 (en) | Omega-6 enriched pufa phospholipids | |
| CL2018003419A1 (es) | Producción de ácidos grasos poliinsaturados de cadena larga en células vegetales. (divisional solicitud 201403402) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ERR | Error or correction |
Free format text: THE OWNER HAS BEEN CORRECTED TO 3538991, ABBOTT LABORATORIES, 377/AP6-1, 100 ABBOTT PARK ROAD, IL, ABBOTT PARK 60064, US Effective date: 20160929 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 MAR 2018 BY THOMSON REUTERS Effective date: 20170221 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 MAR 2019 BY THOMSON REUTERS Effective date: 20180217 |
|
| LAPS | Patent lapsed |